WIPI2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.033200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.432400E-01
Normal-vs-Stage2
6.439800E-01
Normal-vs-Stage3
1.787780E-01
Normal-vs-Stage4
5.244400E-01
Stage1-vs-Stage2
7.645000E-01
Stage1-vs-Stage3
2.550200E-01
Stage1-vs-Stage4
8.031200E-01
Stage2-vs-Stage3
1.359970E-01
Stage2-vs-Stage4
9.344200E-01
Stage3-vs-Stage4
3.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.435600E-01
Normal-vs-AfricanAmerican
9.256200E-01
Normal-vs-Asian
7.474800E-01
Caucasian-vs-AfricanAmerican
4.042200E-01
Caucasian-vs-Asian
1.193390E-01
AfricanAmerican-vs-Asian
8.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.666800E-01
Normal-vs-Female
8.430000E-01
Male-vs-Female
2.830000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.506200E-01
Normal-vs-Age(41-60Yrs)
9.620400E-01
Normal-vs-Age(61-80Yrs)
5.251600E-01
Normal-vs-Age(81-100Yrs)
8.419800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.860000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.139150E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.736600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.291910E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.319800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.235600E-01
Normal-vs-Daily Drinker
9.494400E-01
Normal-vs-Weekly Drinker
8.903000E-01
Normal-vs-Occasional Drinker
9.448800E-01
Normal-vs-Social Drinker
9.980200E-01
Non Drinker-vs-Daily Drinker
4.902100E-02
Non Drinker-vs-Weekly Drinker
1.404550E-01
Non Drinker-vs-Occasional Drinker
2.887600E-02
Non Drinker-vs-Social Drinker
7.935600E-02
Daily Drinker-vs-Weekly Drinker
7.378800E-01
Daily Drinker-vs-Occasional Drinker
9.619000E-01
Daily Drinker-vs-Social Drinker
9.095000E-01
Weekly Drinker-vs-Occasional Drinker
7.104600E-01
Weekly Drinker-vs-Social Drinker
8.228800E-01
Occasional Drinker-vs-Social Drinker
9.264400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.929200E-01
Normal-vs-Grade 2
9.507000E-01
Normal-vs-Grade 3
9.806600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.580000E-01
Grade 1-vs-Grade 3
6.798400E-01
Grade 1-vs-Grade 4
9.929200E-01
Grade 2-vs-Grade 3
3.045000E-01
Grade 2-vs-Grade 4
9.507000E-01
Grade 3-vs-Grade 4
9.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.806200E-01
Normal-vs-NonDiabetic
8.927200E-01
Diabetic-vs-NonDiabetic
5.390100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.936600E-01
Normal-vs-NoPancreatitis
7.209600E-01
Pancreatitis-vs-NoPancreatitis
3.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.824600E-01
Normal-vs-N1
6.666600E-01
N0-vs-N1
7.845800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.919400E-01
Normal-vs-TP53-NonMutant
8.324800E-01
TP53-Mutant-vs-TP53-NonMutant
7.367400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
